Now showing items 1-10 of 24
Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study
(Elsevier B.V., 2010-07-01)
Aims: The effects of glargine insulin therapy in pregnancies are not well established. We compared maternal and neonatal outcomes of women with pregestational and gestational diabetes treated with glargine or NPH ...
Degludec: The New Ultra-long Insulin Analogue
(BIOMED CENTRAL LTDLONDON, 2015)
Custo-utilidade da insulina glargina e insulina isófana (NPH) para o tratamento de pacientes com diabetes mellitus tipo 2 atendidos no Sistema Único de Saúde do Município de Recife
(Universidade Federal de PernambucoUFPEBrasilPrograma de Pos Graduacao em Gestao e Economia da Saude, 2017)
Insulin analogues in the treatment of diabetes in pregnancyAnálogos de insulina no tratamento do diabetes gestacional
(Sociedade Brasileira de Endocrinologia e Metabologia, 2012)
Pregnancy affects both maternal and fetal metabolism, and even in non-diabetic women, it exerts a diabetogenic effect. Among pregnant women, 2% to 14% develop gestational diabetes. Pregnancy can also occur in women with ...
DESENVOLVIMENTO E VALIDAÇÃO DE MÉTODOS CROMATOGRÁFICOS PARA AVALIAÇÃO DE TEOR/POTÊNCIA DE INSULINA GLARGINA
(Universidade Federal de Santa MariaBRFarmacologiaUFSMPrograma de Pós-Graduação em Ciências Farmacêuticas, 2016-03-30)
hans, and is secreted into the bloodstream. It plays and important role in regulating the metabolic activities of the body, particularly the homeostasis of the blood glucose. Insulin glargine is a recombinant human insulin ...
Diabetes and pregnancy: An update of the problem
Pregnancies complicated by diabetes account for about 7% of all pregnancies attended by the Brazilian Unified Healthcare System (SUS) and are one of the main causes of maternal/perinatal morbidity and mortality in Brazil. ...